home > news > detailed info

Aptar Pharma Co Organizer and Diamond Sponsor of RDD Europe 2019 Conference in Estoril Portugal

Aptar Pharma

Crystal Lake, Illinois, March 21, 2019

Aptar Pharma, the leader in respiratory drug delivery systems, is proud to announce its coorganization and diamond sponsorship of the Respiratory Drug Delivery (RDD®) Europe 2019 scientific conference, connecting pulmonary and nasal drug delivery experts from around the world in Estoril, Portugal from May 7-10, 2019.

One of the largest respiratory health conferences worldwide, RDD Europe 2019 is a premium, interactive three-day conference offering a prestigious program that includes a plenary lecture and seven plenary sessions hosted by industry experts - including a U.S. FDA speaker - who will share their perspectives and latest accomplishments in pulmonary and nasal drug delivery. This international symposium also offers delegates the latest insights into issues facing the global inhalation community, and numerous business networking opportunities.

As part of their Diamond Sponsorship, Aptar Pharma will lead three interactive workshops dedicated to connected health. Entitled “The Future of Connected Medicines: Promise and Potential Pitfalls”, these sessions will take place on Wednesday, May 8 and will be presented by Sai Shankar Director, Business Development - Connected Devices at Aptar Pharma along with David Van Sickle, Co-founder and CEO at Propeller Health.

Reaffirming their respiratory expertise, Aptar Pharma will also present two scientific posters during RDD Europe 2019, co-presented by Dr. Gerallt Williams, Director Scientific Affairs, Aptar Pharma:
· “Human Factor studies for unit-dose nasal sprays – a case study”, copresented by G. Williams, B. Grosjean, D. Chopard, P. Schwartz, J. Cabiddu
· “Investigation of leachables from pMDIs containing HFA 152a”, co-presented by S. Sarrailh, A. Piquenot, O. Michelet, G. Williams.

In addition to co-organizing the conference, Aptar Pharma will showcase their extensive portfolio of MDIs, DPIs and BAIs, including the growing range of connected devices, at an interactive Exhibit Table. Available as either add-on or fully integrated, Aptar’s c-devices can deliver improved patient health outcomes through better adherence. Also, discover the portfolio of active packaging solutions from Aptar CSP Technologies, now part of the Aptar family, which can help optimize your drug product’s packaging environment.

As Platinum Sponsor, Aptar Pharma will be hosting the Gala Dinner at RDD Europe 2019, which will take place on Thursday May 9 at Sud Lisboa, located on the banks of the Tagus River in Lisbon. Gael Touya, President of Aptar Pharma, will be on hand to welcome guests to this much-anticipated event, which combines fine-cuisine, dancing and networking to cap off the conference.

Register now at for RDD Europe 2019 – a mustattend conference for companies involved in research, development, testing and marketing of medicines, as well as devices and services associated with pulmonary or nasal products.

About Aptar Pharma
Aptar Pharma is part of AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing, sealing and active packaging solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. Aptar uses insights, design, engineering and science to create innovative packaging technologies that build brand value for its customers, and, in turn, make a meaningful difference in the lives, looks, health and homes of people around the world. Aptar is headquartered in Crystal Lake, Illinois and has over 14,000 dedicated employees in 18 different countries. For more information, visit

Media Contact:
Aptar Pharma
Carolyn Penot
+33 1 39 17 20 38
phone +33 (0)13 917 2020
email 36-38 Rue de la Princesse, 78431 Louveciennes
Print this page
Send to a friend
News and Press Releases

Turkish Cargo keeps growing in the first quarter of 2019

Maintaining its accomplished operations from Ataturk and Istanbul airports as "Dual Hub", the global brand of Turkish Cargo continued its strong growth momentum during the first quarter of the year despite the shrinkage of the global air cargo sector.
More info >>

White Papers

Clinical Trials in Russia Orange Paper: 1st Quarter 2014

Synergy Research Group

In summary, Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

Industry Events

BioPharm America™ 2019—12th Annual International Partnering Conference

11-12 September 2019, Boston Convention and Exhibition Center (BCEC), Boston, MA 02210 USA

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Life science executives from around the world gather to identify, meet and to enter into strategic relationships facilitated by partneringONE®, the world’s leading web-based partnering system. BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®. BioPharm America annually attracts 800+ delegates from over 500 companies who participated in 2,300+ scheduled one-to-one meetings. BioPharm America is now part of Biotech Week Boston, and together they draw a total of over 4,500 life science leaders, scientists and innovators.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement